ABUS vs WBD · P/E 5.4, rev $6.2M vs rev $39.32B
Arbutus Biopharma Corp (ABUS) versus Warner Bros Discovery Inc (WBD) — a side-by-side from cached financials, not a winner call.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
Warner Bros Discovery Inc (WBD) is a entertainment company listed on NASDAQ.
Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
Latest reported WBD revenue for 2024-12-31 was $39.32B. Net income was -$11.48B. Revenue was down 4.8% from 2023-12-31 to 2024-12-31. WBD currently screens at market cap $66.93B.
ABUS currently screens at market cap $883.0M and trailing P/E 5.4. WBD currently screens at market cap $66.93B.
Not investment advice. Open the ABUS and WBD stock pages for the full models.
Not investment advice.